Phase I trial of concurrent erlotinib, celecoxib, and reirradiation for recurrent head and neck cancer

被引：2
|
作者：
Kao, J. [1 ]
Packer, S. H. [1 ]
Teng, M. [1 ]
Gupta, V. [1 ]
Misiukiewicz, K. [1 ]
Genden, E. M. [1 ]
机构：
[1] Mt Sinai Sch Med, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.5561
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5561
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Results of Reirradiation with Stereotactic Radiotherapy in Recurrent Head and Neck Cancer
    Sari, S. Yuce
    Cengiz, M.
    Dogan, A. Elmali
    Yilmaz, M. T.
    Yazici, G.
    Ozyigit, G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E386 - E386
  • [22] Phase I trial of pemetrexed in combination with cetuximab and concurrent radiotherapy in head and neck cancer (HNC)
    Gibson, M. K.
    Kararnouzis, M. V.
    Smith, R.
    Heron, D. E.
    Ferris, R.
    Lai, S.
    Kim, S.
    Johnson, J.
    Grandis, J.
    Argiris, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S454 - S455
  • [23] Phase I trial of pemetrexed, cetuximab, and concurrent radiotherapy (RT) in head and neck cancer (HNC)
    Gibson, M. K.
    Smith, R. P.
    Heron, D. E.
    Ferris, R. L.
    Lai, S. Y.
    Kim, S. W.
    Boyer, T.
    Johnson, J. T.
    Grandis, J. R.
    Argiris, A. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [24] Phase I trial of pemetrexed in combination with cetuximab and concurrent radiotherapy in patients with head and neck cancer
    Argiris, A.
    Karamouzis, M. V.
    Smith, R.
    Kotsakis, A.
    Gibson, M. K.
    Lai, S. Y.
    Kim, S.
    Branstetter, B. F.
    Shuai, Y.
    Romkes, M.
    Wang, L.
    Grandis, J. R.
    Ferris, R. L.
    Johnson, J. T.
    Heron, D. E.
    ANNALS OF ONCOLOGY, 2011, 22 (11) : 2482 - 2488
  • [25] Phase I trial of concurrent tirapazamine, cisplatin, and radiotherapy in patients with advanced head and neck cancer
    Rischin, D
    Peters, L
    Hicks, R
    Hughes, P
    Fisher, R
    Hart, R
    Sexton, M
    D'Costa, I
    von Roemeling, R
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (02) : 535 - 542
  • [26] Prospective Trial of Synchronous Bevacizumab, Erlotinib, and Concurrent Chemoradiation in Locally Advanced Head and Neck Cancer
    Yoo, David S.
    Kirkpatrick, John P.
    Craciunescu, Oana
    Broadwater, Gloria
    Peterson, Bercedis L.
    Carroll, Madeline D.
    Clough, Robert
    MacFall, James R.
    Hoang, Jenny
    Scher, Richard L.
    Esclamado, Ramon M.
    Dunphy, Frank R.
    Ready, Neal E.
    Brizel, David M.
    CLINICAL CANCER RESEARCH, 2012, 18 (05) : 1404 - 1414
  • [27] Reirradiation in head and neck cancer
    Blanchard, P.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S352 - S352
  • [28] Continuous course reirradiation with concurrent weekly chemotherapy for patients with unresectable recurrent head and neck
    Sadasiwan, C
    Schultz, C
    Firat, S
    Campbell, B
    Wong, S
    LUNG CANCER, 2004, 46 : S80 - S80
  • [29] Reirradiation alternating with docetaxel and cisplatin in inoperable recurrence of head-and-neck cancer:: A prospective phase I/II trial
    Hehr, T
    Classen, J
    Belka, C
    Welz, S
    Schäfer, J
    Koitschev, A
    Bamberg, M
    Budach, W
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (05): : 1423 - 1431
  • [30] REIRRADIATION WITH INTENSITY-MODULATED RADIOTHERAPY IN RECURRENT HEAD AND NECK CANCER
    Zwicker, Felix
    Roeder, Falk
    Hauswald, Henrik
    Thieke, Christian
    Timke, Carmen
    Schlegel, Wolfgang
    Debus, Juergen
    Muenter, Marc W.
    Huber, Peter E.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2011, 33 (12): : 1695 - 1702
12345